Provided by Tiger Trade Technology Pte. Ltd.

Journey Medical Corp

8.35
0.0000
Post-market: 8.350.00000.00%17:45 EST
Volume:55.05K
Turnover:460.95K
Market Cap:277.69M
PE:-22.91
High:8.53
Open:8.49
Low:8.33
Close:8.35
52wk High:9.56
52wk Low:4.67
Shares:33.26M
Float Shares:20.77M
Volume Ratio:0.75
T/O Rate:0.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3645
EPS(LYR):-0.7181
ROE:-47.05%
ROA:-4.60%
PB:10.72
PE(LYR):-11.63

Loading ...

BRIEF-Journey Medical Corp Entered Into Sales Agreement To Offer And Sell Up To 3.75 Million Shares Of Common Stock

Reuters
·
Jan 24

Journey Medical Corp: Entered Into Sales Agreement to Offer and Sell up to 3.75 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Jan 24

Journey Medical Files $150 Million Mixed Shelf

MT Newswires Live
·
Jan 16

Journey Medical files $150M mixed securities shelf

TIPRANKS
·
Jan 16

Journey Medical Corp Files for Mixed Shelf of up to $150 Mln - SEC Filing

THOMSON REUTERS
·
Jan 16

Journey Medical Reports Emrosi Shows No Impact on Microbiome in Phase 1 Trial

Reuters
·
Dec 10, 2025

Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (Dfd-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology

THOMSON REUTERS
·
Dec 10, 2025

Journey Medical Corp : Alliance Global Partners Raises Target Price to $16 From $10

THOMSON REUTERS
·
Nov 13, 2025

Journey Medical Corporation Reports Strong Q3 2025 Growth

TIPRANKS
·
Nov 13, 2025

Journey Medical Q3 EPS $(0.09) Misses $(0.04) Estimate, Sales $17.631M Miss $18.854M Estimate

Benzinga
·
Nov 13, 2025

Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

GlobeNewswire
·
Nov 13, 2025

Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

GlobeNewswire
·
Nov 05, 2025

Journey Medical presented efficacy data from two studies on Emrosi

TIPRANKS
·
Oct 24, 2025

Journey Medical Corporation to Participate in October 2025 Investor Conferences

GlobeNewswire
·
Oct 08, 2025

Lake Street Sticks to Its Buy Rating for Journey Medical Corp (DERM)

TIPRANKS
·
Sep 29, 2025

Journey Medical Corp - Third Amendment Extends Term Loan Maturity to June 27, 2028 - SEC Filing

THOMSON REUTERS
·
Sep 27, 2025

Journey Medical Corp - on Sept 25, Enters Third Amendment to Credit Agreement - SEC Filing

THOMSON REUTERS
·
Sep 27, 2025

Journey Medical Corporation Amends Credit Agreement, Extends $25 Million Term Loan Maturity to June 2028

Reuters
·
Sep 27, 2025

Journey Medical Corporation to Participate in September 2025 Investor Conferences

GlobeNewswire
·
Sep 03, 2025

BRIEF-Journey Medical Corp May Sell 3,750,000 Shares Of Common Stock

Reuters
·
Aug 29, 2025